POLISCOPE
Back to feed
NewsMother JonesMay 4, 2026United States

Supreme Court Temporarily Protects Access to Abortion Pills via Mail

The U.S. Supreme Court has issued a temporary order maintaining current access to the abortion medication mifepristone, including prescriptions via telemedicine and delivery by mail. This action pauses a lower court ruling that would have restricted these methods while the legal challenge from the state of Louisiana proceeds.

abortiontelemedicineSupreme CourtFDAhealthcare access
Read the full story at Mother Jones

Why It Matters

The order ensures that patients nationwide can continue to access abortion medication through and mail-order services until at least May 11, preventing an immediate disruption to services that account for nearly two-thirds of U.S. abortions.

Key Facts

  • The Supreme Court issued a temporary order allowing the continued use of telemedicine and mail-order delivery for mifepristone.
  • The order pauses a Fifth Circuit Court of Appeals ruling that sought to block nationwide access to mifepristone via online providers.
  • The legal stay remains in effect until at least May 11.
  • Nearly two-thirds of abortions in the U.S. currently involve the use of medication.
  • Nearly 30 percent of abortions in the U.S. are performed via telemedicine.
  • The lawsuit was initiated by the state of Louisiana, which argues the FDA's 2023 rule change allowing telemedicine prescriptions was arbitrary and capricious.
  • Mifepristone was first approved by the FDA in 2000.
  • The drug is typically used in a two-pill regimen alongside misoprostol.
  • Louisiana classifies mifepristone and misoprostol as controlled substances.
  • The Fifth Circuit ruling had claimed the FDA rule injured Louisiana by undermining state laws and increasing Medicaid costs for emergency care.

Who's Mentioned

organizationSupreme Court of the United States“The judicial body that issued the temporary stay.”organizationDanco Laboratories“Manufacturer of mifepristone that filed an emergency appeal.”personMary Ziegler“Law professor and abortion historian quoted in the article.”organizationGenBioPro“Generic manufacturer of mifepristone that filed an emergency appeal.”organizationFifth Circuit Court of Appeals“Lower court that previously ruled to block telemedicine access to the drug.”personSamuel Alito Jr.“Supreme Court Justice who issued the temporary order.”organizationFood and Drug Administration“Federal agency whose 2023 rule change is being challenged.”locationLouisiana“State that filed the lawsuit against the FDA.”